Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Russell J. Schilder, MD
Fox Chase Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
40 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Center - Calgary
Calgary, Alberta, Canada
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- Community Hospital of Los Gatos
Los Gatos, California, United States
- Chao Family Comprehensive Cancer Center
Orange, California, United States
- Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Rush-Presbyterian-St. Luke'S Medical Center
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Holden Comprehensive Cancer Center at the University of Iowa
Iowa City, Iowa, United States
- Radiation Oncology Branch
Bethesda, Maryland, United States
- Tufts University School of Medicine
Boston, Massachusetts, United States
- University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Ellis Fischel Cancer Center
Columbia, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Cooper Hospital/university Medical Center
Camden, New Jersey, United States
- Cancer Center of Albany Medical Center
Albany, New York, United States
- University of Rochester Cancer Center
Rochester, New York, United States
- State University of New York Health Sciences Center - Stony Brook
Stony Brook, New York, United States
- Lineberger Comprehensive Cancer Center, Unc
Chapel Hill, North Carolina, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Comprehensive Cancer Center at Wake Forest University
Winston-Salem, North Carolina, United States
- Barrett Cancer Center, the University Hospital
Cincinnati, Ohio, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Arthur G. James Cancer Hospital - Ohio State University
Columbus, Ohio, United States
- University of Oklahoma College of Medicine
Oklahoma City, Oklahoma, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Kimmel Cancer Center of Thomas Jefferson University - Philadelphia
Philadelphia, Pennsylvania, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Brookview Research, Inc.
Nashville, Tennessee, United States
- Simmons Cancer Center - Dallas
Dallas, Texas, United States
- University of Texas - Md Anderson Cancer Center
Houston, Texas, United States
- Cancer Center at the University of Virginia
Charlottesville, Virginia, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Tacoma General Hospital
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2000
- Primary completion
- 31 Oct 2004
- Completion
- —
- Last update posted
- 27 May 2013
- Registered enrollment
- —
- Registry id
- NCT00005031
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.